PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Stroke10.5853/jos.2021.023552022241118-127Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent StrokesJong S. Kim, Jaseong Koo, Dong-Ick Shin, Byung-Su Kim, Jei Kim, Eung-Gyu Kim, Keun-Sik Hong, Hyeju Yihttp://j-stroke.org/upload/pdf/jos-2021-02355.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2021.02355, http://j-stroke.org/upload/pdf/jos-2021-02355.pdf
Atherosclerosis Supplements10.1016/j.atherosclerosissup.2005.09.00320056433-40Cilostazol in secondary prevention of stroke: Impact of the Cilostazol Stroke Prevention StudyMasayasu Matsumotohttps://api.elsevier.com/content/article/PII:S156756880500067X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S156756880500067X?httpAccept=text/plain
Journal of Stroke and Cerebrovascular Diseases10.1016/j.jstrokecerebrovasdis.2019.04.00920192882124-2131Effect of Postural Hypotension on Recurrent Stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) StudyTapan Mehta, Leslie A. McClure, Carole L. White, Addison Taylor, Oscar R. Benavente, Kamakshi Lakshminarayanhttps://api.elsevier.com/content/article/PII:S1052305719301740?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1052305719301740?httpAccept=text/plain
Therapeutic Advances in Cardiovascular Disease10.1177/1753944708093411200825387-405Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?Penelope Talelli, Richard J. Greenwoodhttp://journals.sagepub.com/doi/pdf/10.1177/1753944708093411, http://journals.sagepub.com/doi/pdf/10.1177/1753944708093411
Ischemic Stroke Therapeutics10.1007/978-3-319-17750-2_172016189-194Secondary Prevention after Ischemic Strokes due to Hypercoagulable StatesSalvador Cruz-Floreshttps://link.springer.com/content/pdf/10.1007/978-3-319-17750-2_17
Atherosclerosis10.1016/s0021-9150(99)80683-21999144180Dyslipidemia as a risk factor of cerebral atherosclerosis and the target for secondary preventionB.M. Lypovetsky, G.A. Churakovhttps://api.elsevier.com/content/article/PII:S0021915099806832?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0021915099806832?httpAccept=text/plain
Seminars in Cerebrovascular Diseases and Stroke10.1053/scds.2003.000122003318-17Secondary prevention of small subcortical strokes (SPS3)O BENAVENTE, R HARThttps://api.elsevier.com/content/article/PII:S1528993103800158?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1528993103800158?httpAccept=text/plain
Atherosclerosis Supplements10.1016/s1567-5688(08)70994-2200891248STUDY ON LIPIDS IN CEREBRAL ATHEROSCLEROTIC ISCHEMIC STROKESM. Talebi, M. EhsasatVatanhttps://api.elsevier.com/content/article/PII:S1567568808709942?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1567568808709942?httpAccept=text/plain
Treatment-Related Stroke10.1017/cbo9781139775397.0242016241-254Cerebral venous thrombosishttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/70C94093297F1330A22A2BE94C4EBF9C
Ischemic Stroke Therapeutics10.1007/978-3-319-17750-2_162016169-187Secondary Prevention After Non-atherosclerotic Cerebral VasculopathiesRima M. Daferhttps://link.springer.com/content/pdf/10.1007/978-3-319-17750-2_16